Seeing Is Believing
Currently out of the existing stock ratings of William Tanner, 8 are a HOLD (27.59%), 20 are a BUY (68.97%), 1 are a SELL (3.45%).
Analyst William Tanner, currently employed carries an average stock price target met ratio of 35.4% that have a potential upside of 19.45% achieved within 250 days.
William Tanner’s has documented 59 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on NVAX, Novavax at 15-Jun-2021.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 7/7/2020. The price target of $148 was fulfilled within 21 days with a profit of $43.44 (41.55%) receiving and performance score of 19.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$19
$11.68 (159.56%)
$19
8 days ago
(13-Nov-2024)
15/23 (65.22%)
$10.49 (123.27%)
161
Buy
$26
$18.68 (255.19%)
$23
1 months 11 days ago
(10-Oct-2024)
16/41 (39.02%)
$13.09 (101.39%)
85
Sell
$9
$1.68 (22.95%)
$8
3 months 9 days ago
(12-Aug-2024)
7/9 (77.78%)
$-2.85 (-24.05%)
61
Hold
$18
$10.68 (145.90%)
$13
5 months 7 days ago
(14-Jun-2024)
3/4 (75%)
$3.6 (25.00%)
228
Hold
$10
$2.68 (36.61%)
$110
1 years 7 months 1 days ago
(20-Apr-2023)
1/6 (16.67%)
$1.77 (21.51%)
389
What Year was the first public recommendation made by William Tanner?